نتایج جستجو برای: chronic gvhd

تعداد نتایج: 500551  

2017
Mathilde Ruggiu Wendy Cuccuini Karima Mokhtari Véronique Meignin Régis Peffault de Latour Marie Robin Flore Sicre de Fontbrune Aliénor Xhaard Gérard Socié David Michonneau

RATIONALE Central nervous system (CNS) involvement of graft versus host disease (GvHD) is a rare cause of CNS disorders after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Chronic CNS GvHD symptoms are heterogeneous and include cerebrovascular manifestations, demyelinating disease and immune-mediated encephalitis. CNS-Acute GvHD is not formally defined in literature. PATIENT...

Journal: :Blood 2006
Chunyan Zhang Ivan Todorov Zhifang Zhang Yinping Liu Fouad Kandeel Stephen Forman Samuel Strober Defu Zeng

Chronic graft-vs-host disease (GVHD) is a major cause of morbidity and mortality of long-term survivors of allogeneic hemato-poietic cell transplantation (HCT). Chronic GVHD can have features of an autoimmune collagen vascular disease with clinical manifestations similar to autoimmune scleroderma and systemic lupus erythematosus (SLE). However, the pathogenesis of chronic GVHD is poorly underst...

2017
Masahiko Fukatsu Takenobu Murakami Hiroshi Ohkawara Shunichi Saito Kazuhiko Ikeda Suguru Kadowaki Itaru Sasaki Mari Segawa Tomoko Soeda Akihiko Hoshi Hiroshi Takahashi Akiko Shichishima-Nakamura Kazuei Ogawa Yoshihiro Sugiura Hitoshi Ohto Yasuchika Takeishi Takayuki Ikezoe Yoshikazu Ugawa

BACKGROUND Chronic graft-versus-host disease (GVHD) appears several months following allogenic hematopoietic stem cell transplantation (HSCT) and is clinically analogous to autoimmune disorder. Polymyositis is a common neuromuscular disorder in chronic GVHD, but myasthenia gravis (MG) is extremely rare. Hence, its pathophysiology and treatment have not been elucidated. CASE PRESENTATION A 63-...

2015
Rehan Khan Sridevi Nair Tullika Seth Pravas Mishra Manoranjan Mahapatra Tushar Agarwal Radhika Tandon Murugesan Vanathi

BACKGROUND & OBJECTIVES This study was aimed to report the occurrence of ocular graft versus host disease (oGVHD) in allogeneic haematopoietic stem cell transplantation (allo-HSCT) patients in a tertiary care hospital setting. METHODS A cross-sectional study of ocular surface of allo-HSCT patients was done. Slit lamp biomicroscopy, symptom score, tear meniscus height, fluorescein tear break-u...

Journal: :Blood 2011
Gerard Socié

Chronic graft-versus-host disease (GVHD) is a frequent but highly polymorphic complication of allogeneic stem cell transplantation. Its clinical presentation varies from few lichenoid skin lesions to a highly aggressive disease with multiple organ involvement mimicking autoimmune diseases such as scleroderma. Since its first clinical description in 1980,1 clinicians have tried to characterize t...

Journal: :Blood 2007
Xiao Chen Sanja Vodanovic-Jankovic Bryon Johnson Melissa Keller Richard Komorowski William R Drobyski

Graft-versus-host disease (GVHD) remains the major complication after allogeneic bone marrow transplantation (BMT). The process whereby acute GVHD mediated by alloreactive donor T cells transitions into chronic GVHD, which is characterized by prominent features of auto-immunity, has long been unresolved. In this study, we demonstrate that GVHD-associated autoimmunity and, by extension, chronic ...

Journal: :Blood 2012
Hemalatha Rangarajan Maryam Yassai Hariharan Subramanian Richard Komorowski Megan Whitaker Jack Gorski William R Drobyski

Chronic GVHD is a major cause of morbidity and mortality in allogeneic stem cell transplantation recipients and typically develops from antecedent acute GVHD. In contrast to acute GVHD, chronic GVHD has much broader tissue involvement and clinical manifestations that bear striking similarity to what is observed in autoimmune diseases. How autoimmunity arises out of alloimmunity has been a longs...

Journal: :Blood 1990
T P Loughran K Sullivan T Morton C Beckham M Schubert R Witherspoon G Sale J Sanders L Fisher H Shulman

We prospectively evaluated 169 patients with a number of screening studies performed between 71 to 121 days after allogeneic marrow transplantation to detect the development of chronic graft-versus-host disease (GVHD). Group 1 patients (n = 78) were asymptomatic and had normal physical examinations at the time of screening and, with a minimum of 8 years follow-up, have not developed chronic GVH...

Journal: :Journal of Korean Medical Science 2003
Gyeong-Won Lee Je-Hwan Lee Soon-Bae Kim Eun-Sil Yu Jae-Lyun Lee Min-Hee Ryu Eunkyoung Kim Seong-Jun Choi Woo-Kun Kim Jung-Shin Lee Kyoo-Hyung Lee

Allogeneic stem cell transplantation (allo-SCT) using related or unrelated donor could eradicate paroxysmal nocturnal hemoglobinuria (PNH) clones and may cure the disease. Chronic graft-versus host disease (GVHD) is a major complication of patients who have undergone allo-SCT. Nephrotic syndrome has been described as one of the rare manifestations of chronic GVHD following the usual myeloablati...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید